Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows provided by (used in) operating activities
Net income (loss)	$ 11,593,050	$ (21,195,316)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and amortization	60,809	2,556
Operating leases amortization	176,980
Issuance of common stock for services	0	732,249
Stock based compensation from issuance of options	3,197,384	5,760,432
(Gain) loss on settlement of debt	(16,503)	49,983
Changes in assets and liabilities:
Accounts receivable	(2,729,050)	7,207,359
Prepaid expenses and other current assets	(788,194)	465,705
Accounts payable and accrued liabilities	361,223	(1,924,032)
License fees payable	(8,100,000)	8,100,000
Accrued salaries and wages	154,017	370,155
Decrease in operating lease liabilities	(173,826)
Royalty payable	621,877	(409,707)
Deferred revenue	(293,877)	317,644
Net cash provided by (used in) operating activities	4,063,890	(522,972)
Cash flows used in investing activities
Purchase of property and equipment	(302,475)	0
Net cash used in investing activities	(302,475)	0
Cash flows provided by financing activities
Proceeds from exercise of options and warrants	2,675,420	34,000
Payment of financing costs	(70,000)	(166,419)
Proceeds from sale of common stock	0	17,153,126
Net cash provided by financing activities	2,605,420	17,020,707
Net increase in cash and cash equivalents	6,366,835	16,497,735
Cash and cash equivalents, beginning of year	24,613,638	8,115,903
Cash and cash equivalents, end of year	30,980,473	24,613,638
Supplemental disclosure
Taxes paid during the year	800	174,000
Non-Cash Investing and Financing Transactions
Cashless exercise of options	19	50
Issuance of common stock to net profit partner	0	1,600,000
Issuance of common stock as settlement of liability	160,906	100,000
Right of use assets obtained in exchange for new lease obligations	948,575
Offset of deferred financing costs against APIC	$ 0	$ 209,042